<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <title>nOPV2 Distribution Analysis</title>
  <title>Public Health Data Portfolio</title>
  <style>
    body {
      font-family: Arial, sans-serif;
      background: #f7f9fb;
      color: #222;
      max-width: 1000px;
      margin: auto;
      padding: 25px;
    }
    header {
      border-bottom: 3px solid #0b5ed7;
      padding-bottom: 15px;
      margin-bottom: 30px;
    }
    h1 { color: #0b5ed7; }
    .tagline {
      font-size: 1.1em;
      color: #555;
    }
    section {
      background: #ffffff;
      padding: 20px;
      margin-bottom: 25px;
      border-radius: 10px;
      box-shadow: 0 2px 6px rgba(0,0,0,0.05);
    }
    ul { padding-left: 20px; }
    a {
      color: #0b5ed7;
      text-decoration: none;
      font-weight: 600;
    }
    .project {
      margin-bottom: 15px;
    }
  </style>
</head>
<body>
  
</head>
<body>

<header>
  <h1>nOPV2 Distribution & Coverage Analysis</h1>
  <p class="subtitle">
    Public Health Data Analysis Project | Polio Outbreak Response
  </p>
</header>

<section>
  <h2>Background</h2>
  <p>
    Novel Oral Polio Vaccine type 2 (nOPV2) is deployed during outbreak responses
    to circulating vaccine-derived poliovirus type 2 (cVDPV2). Efficient
    distribution and utilization are critical to achieving rapid outbreak
    control.
  </p>
</section>

<section>
  <h2>Objective</h2>
  <ul>
    <li>Assess nOPV2 distribution efficiency</li>
    <li>Estimate vaccination coverage by district</li>
    <li>Identify wastage and supply-demand gaps</li>
  </ul>
</section>

<section>
  <h2>Data</h2>
  <p>
    Simulated district-level campaign data representing operational indicators
    commonly used in polio outbreak response.
  </p>
  <a href="data/nopv2_distribution.csv">Download dataset</a>
</section>

<section>
  <h2>Methods</h2>
  <ul>
    <li>Data cleaning and analysis using Python (pandas)</li>
    <li>Coverage, utilization, and wastage indicators computed</li>
    <li>Descriptive and comparative analysis by district and region</li>
  </ul>
</section>

<section>
  <h2>Key Findings</h2>
  <ul>
    <li>National coverage exceeded 90%, with sub-national variability</li>
    <li>Several districts recorded utilization below optimal levels</li>
    <li>Higher wastage observed in low-utilization districts</li>
  </ul>
</section>

<section>
  <h2>Visualizations</h2>
  <img src="visuals/coverage_by_district.png" alt="Coverage by district">
</section>

<section>
  <h2>Policy Recommendations</h2>
  <ul>
    <li>Risk-based allocation of nOPV2 doses</li>
    <li>Real-time stock and utilization monitoring</li>
    <li>Strengthened microplanning in low-performing districts</li>
  </ul>
</section>

<section>
  <h2>Project Links</h2>
  <ul>
    <li><a href="https://github.com/yourusername/nopv2-distribution-analysis">GitHub Repository</a></li>
    <li><a href="../">Back to Portfolio</a></li>
  </ul>
</section>

<footer>
  <p>Â© 2026 Aria | Public Health Data Analyst</p>
</footer>

</body>
</html>
